PROTEOMIC ANALYSIS OF MICRODISSECTED BENIGN AND MALIGNAN
$0Z01FY2004SCNIH
Clinical Sciences
Investigators
Linked publications & trials
Paper 18840642Paper 18559586Paper 17278115Paper 17255292Paper 17222609Paper 17017437Paper 15937070Paper 15852235Paper 12501164
Abstract
We will study the differences in cellular protein expression between normal and pathological thyroid tissues using proteomics technology, and identified several proteins that are differentially expressed in thyroid lesions with both benign and malignant proliferative potential. The continuation of this line of work will hopefully lead to the discovery of new molecular markers important in the diagnosis and treatment of Thyroid Ca.
View original record on NIH RePORTER →